Navigation Links
Heartburn Drugs May Raise Pneumonia Risk
Date:12/20/2010

hat found that taking PPIs increased the chances of developing pneumonia by 27 percent, while taking H2 blockers resulted in a 22 percent increased chance of pneumonia.

An analysis of 23 randomized clinical trials found people taking H2 blockers had a 22 percent increased chance of getting hospital-acquired pneumonia.

"Gastroenterologists in general have become more cognizant of the fact that these drugs can have some side effects," said Dr. Michael Brown, a gastroenterologist at Rush University Medical Center in Chicago. "For a long time, we were very happy to suppress people's acid without thinking about the consequences. Now we are starting to see some issues."

Hospital patients are often given acid-suppressing drugs, with studies showing them prescribed to as many as 40 to 70 percent of hospitalized patients. The authors suggest these drugs may be a cause of hospital-acquired pneumonia.

The rationale is that patients in intensive care units have decreased blood flow to the stomach, which can lead to ulcers and bleeding, a life-threatening condition that PPIs can prevent, Brown said.

The problem is that many patients prescribed the drugs in the hospital also go home with a prescription and continue taking PPIs, perhaps unnecessarily, Brown said.

According to the study, one in every 200 inpatients treated with acid-suppressing medications will develop pneumonia. The increased risk isn't huge, but it's still meaningful, Brown said.

"These drugs are given out like candy. You are talking about very large numbers of people taking the drugs," Brown said. "The study found a moderate increase in pneumonia, but, given the very large numbers of people who use these drugs, it's very significant."

The most plausible reason why suppressing acid in the stomach might raise the risk of pneumonia, Brown said, is that stomach acid acts as a barrier helping to control harmful bacteria and pathogens.

Not enough stomach ac
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. For Most, Chronic Heartburn Not a Big Risk for Esophageal Cancer
2. No Link Between Heartburn Drugs and Birth Defects: Study
3. Heartburn Drugs, Plavix Seem Safe to Take Together
4. Plavix, Heartburn Drug Safe to Take Together: Study
5. FDA Warns of Fracture Risk With Popular Heartburn Drugs
6. Coming Soon: A Low-Heartburn Coffee?
7. Trio of drugs may combat triple negative breast cancer
8. Drugs are safe, active in patients normally ineligible for clinical trial
9. Certain Breast Cancer Drugs Linked With Heart Risks in Older Women
10. Economist honored for study on impact of new cancer drugs on life expectancy
11. FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Heartburn Drugs May Raise Pneumonia Risk
(Date:8/1/2014)... This week marks a significant milestone ... week of paying commissions to its independent distributor sales ... January 2005 total $1,405,954,677.06. , MonaVie distributors can be ... pays commissions in 18 different currencies, including: AUD, EUR, ... PLN, USD, SGD, KRW, TWD, THB and GBP. ...
(Date:8/1/2014)... A leading dress supplier, Discount-Dress.com, explores a variety of ... any lady’s wardrobe fashionable and exciting. Recently, the company has ... To attract more people, it is now launching a special ... to 65% off. , “Summer is the season of short ... to our collection of ‘ 2014 summer short styles .’ ...
(Date:8/1/2014)... August 01, 2014 Transparency Market ... the addition of a comprehensive report on the ... System Market (Large Volume, Disposable, Syringe, Ambulatory and ... Trends And Forecast, 2013 – 2019’ is now ... http://www.transparencymarketresearch.com . , To begin with, the report ...
(Date:8/1/2014)... CentraComm, a leading managed IT security ... the Pure Storage® Authorized Reseller program. , ... experience designed to meet the rigorous resiliency, scalability, ... diverse markets, and for a variety of high ... years. , The Pure Storage FlashArray was ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, 2014 ... Africa has a well-earned reputation as one of the world,s ... intense medical care can greatly improve a person,s chances of ... wreaks life-threatening havoc within the body by attacking multiple organ ... back on the basics of "good meticulous intensive care," supporting ...
Breaking Medicine News(10 mins):Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2Health News:Discount-Dress.com’s Top Trend Report: 2014 Summer Short Bridesmaid Dresses Now for Sale 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 3Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3
... Lifeclinic International is this year,s Gold Sponsor of the Harvard Business ... Joseph B. Martin Conference Center, Harvard Medical School, November 6 - ... ... 2008 -- Lifeclinic International, Inc. , the world,s leading manufacturer ...
... Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today ... On Tuesday, November 11, 2008 at 2:50 p.m. ... a corporate presentation at the,Rodman & Renshaw 10th Annual ... November 12, 2008 at 3:30 p.m. MST (5:30 p.m. ...
... Product Will Be Sold by A Uniquely-Trained Sales ... ... Group plc,(LSE: PSK) today announced that SANCUSO(R) (Granisetron Transdermal System),is now available ... States. Sancuso was approved by,the U.S. Food and Drug Administration (F.D.A.) in ...
... have vaccination rates far below goals, study finds , , ... adolescents with asthma and other high-risk illnesses are getting ... vaccination rates from 1992 to 2002 for 18,703 adolescents ... conditions. , During the study period, vaccination rates improved, ...
... Fifteen Abstracts Will Be Featured at ASN, ... a leading,provider of kidney care services for those ... DaVita Clinical Research(R) (DCR),recently contributed fifteen abstracts to ... American Society of Nephrology. These,abstracts were developed both ...
... Nov. 4 The Quantum Group,Inc. (Amex: ... today that Noel J. Guillama, President & Chief ... Annual Westergaard,Conference on November 12, 2008. Mr. Guillama ... and Chief Technology & Innovations Officer,and Ron Smith, ...
Cached Medicine News:Health News:Lifeclinic International Lead Sponsor at Harvard Business School Health Conference 2Health News:SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available 2Health News:SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available 3Health News:Too Many High-Risk Teens Not Getting Flu Shots 2Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 2Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 3Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 4Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 2Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 3
(Date:8/1/2014)... LAWRENCE, Mass. , Aug. 1, 2014  NxStage Medical, ... innovative dialysis products, today announced that Jeffrey H. Burbank ... Financial Officer, will present at the 34 th Annual ... Boston, MA , on Wednesday, August 13 ... event will be made available at http://ir.nxstage.com/ .  ...
(Date:8/1/2014)... JUPITER, Fla. , Aug. 1, 2014 ... company whose patented and proprietary technologies are used to ... the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... for the second quarter ended June 30, 2014 after ... host a conference call that day at 5:00 p.m. ...
(Date:7/31/2014)... , July 31, 2014  According to data ... Services, the 2015 average monthly Medicare Part D premium ... far lower than was originally projected, the Pharmaceutical Care ... D program continues to be a bright spot in ... choices in each region and using cutting edge, cost-saving ...
Breaking Medicine Technology:NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3
... GeneXpert(R) System ... ... today announced the U.S. Food & Drug Administration (FDA) categorized,Cepheid,s ... Clinical Laboratory Improvement Amendments (CLIA).,The new test is designed for ...
... Michael J. Fox,Foundation today announced the availability of ... toward transformative treatments and a cure for,Parkinson,s disease., ... researchers through the,Foundation,s Pipeline Programs, five separate initiatives ... drug development pipeline. This includes,early-stage discovery research, translational ...
Cached Medicine Technology:Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 4Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 2Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 3Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 4
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: